Skip to main content
Premium Trial:

Request an Annual Quote

Genedata Partners with EC-Backed Infections and Cancer Consortium

NEW YORK, June 27 (GenomeWeb News) - Genedata today announced a partnership with the Infections and Cancer (INCA) consortium, a European Commission-backed research program to discover the role of chronic infection in the development of cancer.


Genedata will provide research informatics to support the consortium's research. Financial details were not disclosed.


"INCA will help researchers develop new prevention measures and treatments against cancers such as leukemia, stomach cancer, and cervical cancer," Thomas Schulz, INCA's principal coordinator, said in a statement. The consortium will focus on five viruses and the Helicobacter pylori bacterium, Genedata said.


The four-year program kicked off in January and will receive €12.6 million ($15.9 million) of EC funding as part of Europe's Sixth Framework Life-Science-Health program. The consortium includes 30 research organizations from 13 European countries.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.